Oral Presentation No. 53 Dose-related preprocedural patency of the infarct-related artery after zalunfiban (RUC-4) administration upon arrival at the catheterization laboratory in ST-elevation myocardial infarction: insights from the phase IIa study
Publication
, Conference
Rikken, SAOF; Bor, WL; Zheng, KL; Gibson, CM; Granger, CB; Coller, BS; Bentur, O; Lobatto, R; Postma, S; Van 't Hof, AWJ; Ten Berg, JM
Published in: Cardiovascular Research
October 21, 2022
Duke Scholars
Published In
Cardiovascular Research
DOI
EISSN
1755-3245
ISSN
0008-6363
Publication Date
October 21, 2022
Volume
118
Issue
Supplement_2
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Rikken, S. A. O. F., Bor, W. L., Zheng, K. L., Gibson, C. M., Granger, C. B., Coller, B. S., … Ten Berg, J. M. (2022). Oral Presentation No. 53 Dose-related preprocedural patency of the infarct-related artery after zalunfiban (RUC-4) administration upon arrival at the catheterization laboratory in ST-elevation myocardial infarction: insights from the phase IIa study. In Cardiovascular Research (Vol. 118). Oxford University Press (OUP). https://doi.org/10.1093/cvr/cvac157.007
Rikken, Sem A. O. F., W. L. Bor, K. L. Zheng, C. M. Gibson, C. B. Granger, B. S. Coller, O. Bentur, et al. “Oral Presentation No. 53 Dose-related preprocedural patency of the infarct-related artery after zalunfiban (RUC-4) administration upon arrival at the catheterization laboratory in ST-elevation myocardial infarction: insights from the phase IIa study.” In Cardiovascular Research, Vol. 118. Oxford University Press (OUP), 2022. https://doi.org/10.1093/cvr/cvac157.007.
Rikken SAOF, Bor WL, Zheng KL, Gibson CM, Granger CB, Coller BS, et al. Oral Presentation No. 53 Dose-related preprocedural patency of the infarct-related artery after zalunfiban (RUC-4) administration upon arrival at the catheterization laboratory in ST-elevation myocardial infarction: insights from the phase IIa study. In: Cardiovascular Research. Oxford University Press (OUP); 2022.
Rikken, Sem A. O. F., et al. “Oral Presentation No. 53 Dose-related preprocedural patency of the infarct-related artery after zalunfiban (RUC-4) administration upon arrival at the catheterization laboratory in ST-elevation myocardial infarction: insights from the phase IIa study.” Cardiovascular Research, vol. 118, no. Supplement_2, Oxford University Press (OUP), 2022. Crossref, doi:10.1093/cvr/cvac157.007.
Rikken SAOF, Bor WL, Zheng KL, Gibson CM, Granger CB, Coller BS, Bentur O, Lobatto R, Postma S, Van ’t Hof AWJ, Ten Berg JM. Oral Presentation No. 53 Dose-related preprocedural patency of the infarct-related artery after zalunfiban (RUC-4) administration upon arrival at the catheterization laboratory in ST-elevation myocardial infarction: insights from the phase IIa study. Cardiovascular Research. Oxford University Press (OUP); 2022.
Published In
Cardiovascular Research
DOI
EISSN
1755-3245
ISSN
0008-6363
Publication Date
October 21, 2022
Volume
118
Issue
Supplement_2
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology